Origin & tradition
Not traditional: marine omega-3s entered medicine through cardiovascular epidemiology and large randomized trials.
Western tradition · Essential fatty acids
Among the most-trialed supplements in medicine, with emerging evidence on biological-age slowing.
Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.
Not traditional: marine omega-3s entered medicine through cardiovascular epidemiology and large randomized trials.
Key active: EPA & DHA (marine omega-3 fatty acids).
EPA and DHA modulate inflammation (resolvins), membrane function, and triglycerides; the DO-HEALTH trial reported small reductions in biological-aging markers and infections in older adults.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| Triglycerides | Decreases | Strong | A |
| Cardiovascular events | Decreases | Moderate | B |
| Systemic inflammation (CRP) | Decreases | Moderate | B |
| Blood pressure | Decreases | Minor | B |
| Cognitive function / DHA levels | Increases | Moderate | B |
| Dry eye symptoms | Decreases | Moderate | B |
| Liver fat (NAFLD) | Decreases | Moderate | B |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
Look for combined EPA+DHA total, not total fish oil weight. Prescription-strength omega-3 (Vascepa, Lovaza) used at 4g/day for triglyceride reduction. Algal oil is the direct DHA source for vegans.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Very large human RCT base; aging markers emerging (DO-HEALTH)
EPA and DHA modulate inflammation (resolvins), membrane function, and triglycerides; the DO-HEALTH trial reported small reductions in biological-aging markers and infections in older adults.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-07-19. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Compare the evidence
Suppliers
Tell us what you need and we will source suppliers for you.